Please assess the completion status of the following clinical trial:

Trial Title: Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosed as 2- or 3-walled vertical intrabony defect \>=3 mm deep from the top of the remaining alveolar bone~* with mobility of the tooth of degree 2 or less~* with width of attached gingiva appropriate for Guided Tissue Regeneration~Exclusion Criteria:~* concomitant administration of adrenal cortical steroid within 4 wks after the surgery~* administeration of calcium antagonist during the 4 weeks preceding administration of the investigational drug~* coexisting malignant tumour or history of the same~* coexisting diabetes (HbA1C \>= 6.5%)~* an extremely poor nutritional condition (serum albumin concentration \<2 g/dL)~* pregnancy or lactation

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- P (Type: PLACEBO_COMPARATOR): None
- L (Type: EXPERIMENTAL): low dose (0.03 %)
- M (Type: EXPERIMENTAL): medium dose (0.1 %)
- H (Type: EXPERIMENTAL): high dose (0.3 %)

Based on this trial design, predict the completion outcome and termination type (if applicable).